Does Lesion Location in Geographic Atrophy Impact Quality of Life?
A recent study tries to paint a clearer picture of the correlation between structural and functional markers of geographic atrophy.
Read More
Author: Teresa Sellinger
Lifestyle Intervention Linked With Higher pCR in Women on Neoadjuvant Chemo
Patients in the intervention group significantly improved their diet quality and physical activity levels from baseline, compared with those in usual care.
Read More
FOLFIRINOX Equals Gemcitabine-Based Chemoradiotherapy for Pancreatic Cancer
Neoadjuvant FOLFIRINOX and gemcitabine-based chemoradiotherapy were comparably effective for pancreatic cancer.
Read More
Erdafitinib Similar to Pembrolizumab for Urothelial Cancer
Erdafitinib did not outperform pembrolizumab as second-line treatment for metastatic urothelial carcinoma.
Read More
Short Induction Chemo Improves Survival in Advanced Cervical Cancer
Carboplatin/paclitaxel induction chemotherapy, directly followed by standard chemoradiotherapy, improved survival in locally advanced cervical cancer.
Read More
First Effective First-Line Chemo/Immunotherapy Combo for Urothelial Cancer
Nivolumab plus chemotherapy is the first combination to outperform chemotherapy alone as first-line treatment for unresectable or metastatic urothelial cancer.
Read More
Superior PFS With Sotorasib in Colorectal Cancer
Patients with KRAS (G12C)-mutated, metastatic colorectal cancer (CRC) benefit from combination sotorasib and panitumumab
Read More
“LAG Time” Promising First-Line Treatment for Metastatic NSCLC
Soluble LAG-3 protein eftilagimod alpha combined with pembrolizumab shows promising clinical efficacy as first-line treatment for advanced or metastatic NSCLC.
Read More
How Fair Is the Standard of Care?
If every patient is unique, can an overarching metric really be pinned down enough to declare that a given doctor was negligent as a legal certainty?
Read More
Innovative & Insightful IBS-C Peer to Peer eBook
An innovative, curated ebook featuring insightful IBS-C findings and input from key opinion leaders in the field of gastroenterology.
Read More
Q&A: Collaboration Improves PrEP Uptake in Latino MSM
Collaboration among healthcare providers and community-based organizations may be a viable strategy to increase PrEP uptake among Latino MSM.
Read More
Q&A: Availability of Multiple Options for NSCLC is “Very Exciting”
Selecting a treatment for operable non-small cell lung cancer from the many options available involves consideration of tumor stage and biomarkers.
Read More
Primary Care Intervention Aids Patient Follow-Up for Abnormal Cancer Screening
Primary care clinicians take a “whole person” approach and are responsible for a wide range of preventive healthcare efforts.
Read More
Healthcare Organizations Can Do More for Women Leaders in Academic Medicine
Women are underrepresented in leadership positions in a wide range of industries, and medicine is no exception. Healthcare organizations can do more for women.
Read More
Addressing New Challenges in Medical Education
Medical education faces challenges that affect the quality of training and the preparedness of future healthcare workforce.
Read More
In Patients With HIV, Non-Alcoholic Fatty Liver Disease Increases Cardiovascular Risk
Patients with HIV and NAFLD experience a greater risk for adverse cardiovascular outcomes than those with HIV alone.
Read More
Functional MRI Identifies Changes in Cerebral Regional Homogeneity Among Patients With TD
Resting-state functional MRI results show that patients with schizophrenia and tardive dyskinesia have altered cerebral regional homogeneity.
Read More
Selpercatinib Doubles Progression-Free Survival in RET-Mutated NSCLC
Selpercatinib doubled progression-free survival, increased response rate, and delayed pulmonary and physical deterioration in RET fusion-positive NSCLC.
Read More
No Surgery After Neoadjuvant Chemoradiotherapy in Esophageal Cancer?
Active surveillance after neoadjuvant chemoradiotherapy may be an alternative to surgery for some with esophageal cancer.
Read More